Replies to post #207538 on Biotech Values

[DewDiligence]

GILD—A deep insight from Jefferies:

http://blogs.barrons.com/stockstowatchtoday/2017/01/04/gilead-sciences-with-new-hire-ma-might-be-on-the-way

We believe the relatively high-profile heme/onc chief hire signals an increasing focus in oncology…and expect Gilead Sciences to more aggressively pursue business development to build out a broader cancer pipeline…